![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA to Rely More on 510(k) Reviews Conducted by Third Parties
FDA to Rely More on 510(k) Reviews Conducted by Third Parties
The FDA released a comprehensive new plan that proposes to rely more on reviews conducted by third parties to streamline its review process and avoid re-reviews of 510(k) applications.
The plan is aimed at improving efficiency and consistency of the premarket notification process, with a goal to have 85 percent of third-party submissions not re-reviewed by the agency by 2021.
FDA Commissioner Scott Gottlieb said the third-party reviews “must be equivalent in rigor and completeness to the kinds of reviews that we’d conduct.”
Upcoming Events
-
11Jul
-
18Jul
-
21Oct